Mayne Pharma Group Ltd (MYX.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -11,076 | -7,950 | -8,335 | -4,842 | -17,091 |
| Net Acquisitions | N/A | 6,854 | 855,267 | N/A | N/A |
| Purchase Of Investment | -512 | N/A | -127,526 | N/A | N/A |
| Sale Of Investment | N/A | 89,268 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -16,489 | -12,912 | -210,840 | -40 | -3,192 |
| Other Investing Activity | -39,996 | -21,811 | -35,081 | -23,644 | -28,964 |
| Investing Cash Flow | $-68,073 | $53,449 | $473,485 | $-28,526 | $-49,247 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 226,933 | 216,304 | 196,430 |
| Debt Repayment | -3,846 | -10,948 | -598,578 | -176,517 | -222,255 |
| Common Stock Repurchased | N/A | -10,932 | -6,223 | N/A | N/A |
| Dividend Paid | N/A | N/A | -45,292 | N/A | N/A |
| Other Financing Activity | 3,290 | 2,030 | -8,726 | -12,186 | -14,615 |
| Financing Cash Flow | $-556 | $-19,850 | $-431,886 | $27,601 | $-40,440 |
| Exchange Rate Effect | 931 | -847 | -2,943 | 6,823 | -8,980 |
| Beginning Cash Position | 110,068 | 92,616 | 96,672 | 97,980 | 137,785 |
| End Cash Position | 59,839 | 110,068 | 92,616 | 96,672 | 97,980 |
| Net Cash Flow | $-51,160 | $18,299 | $-1,113 | $-8,131 | $-30,825 |
| Free Cash Flow | |||||
| Capital Expenditure | -28,989 | -20,862 | -219,585 | -11,853 | -25,097 |
| Free Cash Flow | -28,989 | -20,862 | -219,585 | -11,853 | -25,097 |